Company Filing History:
Years Active: 2003
Title: The Innovations of Petrus Fredericus Wilhelmus Stouten
Introduction
Petrus Fredericus Wilhelmus Stouten is a notable inventor based in Wilmington, DE. He has made significant contributions to the field of pharmaceuticals, particularly in the development of factor Xa inhibitors. His work is recognized for its potential impact on anticoagulant therapies.
Latest Patents
Stouten holds a patent for N-(amidinophenyl)cyclourea analogs as factor Xa inhibitors. This innovation represents a step forward in the search for effective treatments in managing blood coagulation disorders. The patent showcases his expertise and commitment to advancing medical science.
Career Highlights
Stouten is currently employed at Bristol-Myers Squibb Pharma Company, a leading global biopharmaceutical company. His role there allows him to collaborate with other talented professionals in the industry. His contributions have been instrumental in the development of new therapeutic solutions.
Collaborations
Throughout his career, Stouten has worked alongside esteemed colleagues such as Thomas P. Maduskuie, Jr. and Robert Anthony Galemmo, Jr. These collaborations have fostered an environment of innovation and creativity, leading to advancements in their respective fields.
Conclusion
Petrus Fredericus Wilhelmus Stouten is a distinguished inventor whose work in pharmaceuticals has the potential to change lives. His dedication to innovation and collaboration continues to drive progress in medical research.